HMH Maestro
  • Action Center
  • Topics
  • On-Call Schedules
  • CME
  • Helpful Tools
Open main menu
  • Action Center
  • Topics
  • On-Call Schedules
  • CME
  • Helpful Tools
  • Action Center
  • Clinical Alerts
  • Reminder Organ Transplant Program Better Outcomes Short Waiting Period

Reminder Organ Transplant Program Better Outcomes Short Waiting Period

Published:
April 27, 2022

Dear Colleague,

If you have a patient who needs an organ transplant, you want to know that they will receive the best care from a dedicated team of organ transplantation experts, with short wait times for a deceased donor organ and outcomes that exceed national standards. At Hackensack  University Medical Center — one of only a few certified transplant centers in New Jersey —  our transplant surgery team performs kidney and pancreas transplants using the latest donor matching protocols and advanced techniques that are only available at the world’s leading transplant centers. 

Our matching protocols and transplantation techniques allow us to deliver outstanding outcomes and provide world-class care for your patients closer to where they live and work. Your patients will also benefit from: 

  • Significantly shorter wait times for a deceased donor kidney when compared to other transplant centers nationally 
  • Among the best kidney transplant survival rates in the country
  • Patient outcomes that significantly exceed the national average. 
  • The best organ acceptance ratio in the state of NJ
  • Our board-certified transplant surgeons — together with a multidisciplinary team of specialty  physicians, specially trained transplant nurses, and other healthcare support professionals —  will partner with you, your patient, and the patient’s family throughout the whole transplant process. This includes initial evaluation and transplant selection through surgery and follow up care. Additional program benefits include: 
  • Access to Certified Clinical Transplant Coordinators (CCTC), who coordinate  appointments, address financial and insurance issues, and connect patients with resources. 
  • Pioneering organ transplantation care from leaders in the field who routinely publish research findings and innovations in articles and poster presentations, speak at national and international conferences, and participate in national committees. 
  • Access to the latest kidney perfusion technologies, such as the LifePort Kidney  Transporter — an ex vivo hypothermic machine preservation technology that increases a kidney’s viability and lifespan, improving patient outcomes. Our hospital is the only center in New Jersey to routinely perform kidney transplants with machine perfusion technology. 
  • A commitment to quality and safety, as evidenced by our Reducing Avoidable  Readmissions Effectively (RARE) program that monitors post-transplant patients  after discharge to identify those who are at increased risk of readmission. The RARE program contributed to a reduction of readmissions from 26 percent in 2017 to 13  percent in 2018. 
  • Transplant access for new populations through collaboration with Hackensack University  Medical Center’s Bloodless Medicine Program, which provides transfusion-free, safe  kidney transplantation to patients whose personal preferences or religious beliefs  prevent them from accepting blood or blood products. 
  • Leading-edge clinical trials and research designed to improve current and future  transplantation care for donors and recipients, including multicenter trials such as  APOLLO to study the effects of the APO L1 gene in African American transplant donors  and recipients. 
  • A pediatric kidney transplant program providing care for infants as young as one year old and as small as 8 kg in weight. 
  • A track record of successful transplantation in 70- to 80-year-old patients with end-stagerenal disease who may be ineligible for transplant at other area transplant centers.

Hackensack University Medical Center’s Organ Transplant Division also offers a pancreas transplant program — one of only a few such programs in New Jersey that offers this procedure to patients with uncontrolled diabetes causing life-threatening complications. We perform pancreas-kidney as well as pancreas-only transplants.  

We have now expanded to offer consults to patients at Jersey Shore University Medical Center and JFK University Medical Center. If you are interested in learning more about the organ transplantation program at Hackensack University Medical Center, please contact me at 551-996-2608 or by email at Michael.Goldstein@hmhn.org. 

We look forward to partnering with you to provide your patients with the very best transplantation care.

Sincerely,

Michael J. Goldstein, M.D., FACS 

Director of Organ Transplantation 

Hackensack Meridian Health Hackensack University Medical Center 

Associate Professor of Surgery, Hackensack Meridian School of Medicine

*Data from the Scientific Registry for Transplant Recipients

  1. Clinical Alerts
  2. Featured Physicians
  3. Featured Specialties
  4. HMH Partners Updates
  5. Hospitals and Locations
  6. IT Alerts
  7. Leadership Announcements
  8. Legal and Regulatory
  9. Payor Updates
  10. Physician Tips
  11. Quality and Safety
  • Action Center
  • Clinical Alerts
  • Reminder Organ Transplant Program Better Outcomes Short Waiting Period

About HMH Maestro

  • Accessibility Statement
  • Careers

Information

  • Visitors/Guests
  • Patients

Privacy Policy|Terms & Conditions
© 2026
Hackensack Meridian Health, Inc.